The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,556.00
Bid: 12,588.00
Ask: 12,590.00
Change: -34.00 (-0.27%)
Spread: 2.00 (0.016%)
Open: 12,626.00
High: 12,646.00
Low: 12,474.00
Prev. Close: 12,590.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 3-Capitalism and greed gave Britain its vaccine success, PM Johnson says

Tue, 23rd Mar 2021 21:51

* Johnson tries to row back from gaffe on greed

* Praises capitalism in vaccine lead

* UK state money developed the Oxford vaccine

* Communist China moved fast to develop a vaccine
(Adds context on Oxford vaccine)

By Costas Pitas

LONDON, March 24 (Reuters) - Capitalism and greed gave
Britain its success in vaccinating its population, Prime
Minister Boris Johnson told lawmakers in a closed meeting, a
remark that could rile up Brussels at a time when Britain faces
an EU threat to block vaccine imports.

"The reason we have the vaccine success is because of
capitalism, because of greed my friends," The Sun newspaper
quoted Johnson as telling Conservative lawmakers on a Zoom
meeting on Tuesday evening.

Johnson then tried to row back and said: "Actually I regret
saying it" and asked lawmakers repeatedly to "forget I said
that".

Britain has so far mounted the fastest COVID-19 vaccine
programme of any big country. But it now finds its programme
threatened by the EU, which has been far slower in rolling out
vaccines and faces a third wave of infections.

The European Commission is expected on Wednesday to extend
powers to block exports, a move that could hit supply of doses
bound for Britain. Johnson's remarks come after a week in which
British ministers have tried to calm the row.

Downing Street declined to comment on Johnson's remarks when
contacted by Reuters, but unidentified sources gave the BBC a
bizarre array of explanations.

The greed comment, according to the BBC's political editor
Laura Kuenssberg, was apparently a joke about one of his cabinet
colleagues, Chief Whip Mark Spencer, who was gobbling a cheese
and pickle sandwich while the prime minister spoke.

Johnson, Home Secretary Priti Patel said, was talking about
the success of pharmaceutical companies in developing a vaccine
shot in record time.

"Clearly the prime minister was actually referring to the
work that has taken place with pharmaceutical companies and how
we have led the way really in this vaccine development," said
Patel, who was not in the meeting.

Britain was one of several countries that developed a
COVID-19 vaccine shot in record time: the shot developed by
Oxford University and AstraZeneca was approved for use
on Dec. 30 by the British medicines regulator.

The British government helped fund the research, and
AstraZeneca has promised to market it on a not-for-profit basis.

Other vaccines around the world have been developed with
state funding, from Communist China and former communist Russia
to the capitalist United States.
(Reporting by Costas Pitas and Guy Faulconbridge; Editing by
Steve Orlofsky, Rosalba O'Brien, Kate Holton and Peter Graff)

More News
22 Dec 2023 07:17

AstraZeneca gets FDA green light for nerve disease treatment

(Sharecast News) - The US Food and Drug Administration has approved the Wainua nerve disease treatment jointly developed by AstraZeneca and Ionis Pharmaceuticals.

Read more
19 Dec 2023 19:56

US adds 13 companies in China to Unverified List

WASHINGTON, Dec 19 (Reuters) - The United States has added 13 companies in China to a list of entities receiving U.S. exports that officials have been unable to inspect, according to a government notice posted on Tuesday.

Read more
15 Dec 2023 17:14

London stocks log weekly gains as cenbank fest ends

FTSE 100 down 1.0%, FTSE 250 off -0.3%

*

Read more
15 Dec 2023 16:51

LONDON MARKET CLOSE: FTSE 100 underperforms as post-Fed rally cools

(Alliance News) - London's FTSE 100 ended lower on Friday, with profit-taking and some hawkish words from a US policymaker keeping equities in check at the end of a largely positive week for stocks.

Read more
15 Dec 2023 16:29

PRESS: GSK, Astra and AbbVie in US scrutiny over patents - Bloomberg

(Alliance News) - A US senator has accused AstraZeneca PLC, GSK PLC, AbbVie Inc and other drugmakers of "abusing" the patent system to send prices higher, Bloomberg reported on Thursday.

Read more
13 Dec 2023 17:07

UK's FTSE 100 rises as pound slips on GDP data; awaits Fed rate decision

UK economy shrinks by 0.3% in October

*

Read more
12 Dec 2023 16:00

London close: Stocks slip as investors digest US inflation

(Sharecast News) - London's markets finished in the red on Tuesday, as investors digested a slight decrease in consumer inflation in the US, while the UK's unemployment figures remained stable.

Read more
12 Dec 2023 12:07

London midday: FTSE still firmer ahead of US inflation print

(Sharecast News) - London's markets remained relatively stable by midday on Tuesday, with the top-flight index still in the green after fresh jobs data showed a slowdown in wage growth.

Read more
12 Dec 2023 10:08

AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal

Dec 12 (Reuters) - AstraZeneca said on Tuesday it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued at up to $1.1 billion.

Read more
12 Dec 2023 08:53

LONDON MARKET OPEN: FTSE 100 opens higher ahead of US CPI

(Alliance News) - Stock prices in London opened higher on Tuesday, as investors digest the latest UK unemployment data, before turning their eyes to US inflation this afternoon.

Read more
12 Dec 2023 08:37

AstraZeneca acquires vaccine developer Icosavax for USD1.1 billion

(Alliance News) - AstraZeneca PLC confirmed on Tuesday that it will buy Icosavax Inc, boosting its vaccine portfolio with an "innovative" treatment for respiratory viruses.

Read more
12 Dec 2023 07:39

LONDON BRIEFING: UK unemployment unchanged at 4.2%; eyes on US CPI

(Alliance News) - Stocks in London are called to open higher, as investors digest the latest UK unemployment data, before turning their heads to US inflation.

Read more
12 Dec 2023 07:16

AstraZeneca to buy US vaccine maker Icosavax for up to $1.1bn

(Sharecast News) - AstraZeneca said on Tuesday that it has agreed to buy Icosavax - a US-based clinical-stage biopharmaceutical company - for up to $1.1bn.

Read more
12 Dec 2023 02:00

UK companies pause China investment decisions as economy slows, survey shows

BEIJING, Dec 12 (Reuters) - A slowdown in both the Chinese and global economies is the biggest issue affecting British firms in the world's second-largest economy, beating geopolitical concerns and market access barriers, according to the British Chamber of Commerce in China.

Read more
11 Dec 2023 08:15

AstraZeneca says danicopan tests well as blood disorder treatment

(Alliance News) - AstraZeneca PLC on Monday reported "positive results" from a test of danicopan for the treatment of paroxysmal nocturnal haemoglobinuria, or PNH, a rare and severe blood disorder.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.